Technical University Munich
Blue Earth Diagnostics, Siemens Healthineers Partner on Prostate Cancer Theranostics, PET Imaging
Siemens will use data from patients receiving 18F-rhPSMA-7.3 at the Technical University of Munich to build out AI algorithms for treating and diagnosing prostate cancer.
Drug Combination, Biomarker Search Continues in Urothelial Cancer After Mixed ESMO Trial Data
Premium
Following variable Phase III outcomes, investigators are searching for more informative biomarkers than PD-L1 expression in advanced urothelial carcinoma cases.